Method of making cosmetic compositions containing a prebiotic

• US 8,815,538 B2
• Filed: 11/08/2012
• Issued: 08/26/2014
• Est. Priority Date: 11/08/2011
• Status: Expired due to Fees

• Current Assignee: The Procter & Gamble Company
• Original Assignee: The Procter & Gamble Company
• Inventors: Lanzalaco, Anthony Charles, Charbonneau, Duane Larry, Howard, Brian Wilson
• Primary Examiner(s): Kosson, Rosanne
• Application Number:
  US13/672,192
• Publication Number:
  US 20140072533A1
• Time in Patent Office: 656 Days
• Field of Search: 435/39, 435/34, 424/401
• US Class Current: 435/39
• CPC Class Codes: A61K 2800/10 General cosmetic use
• CPC Class Codes: A61K 8/99 from microorganisms other than algae or fungi, e.g. protozoa or bacteria
• CPC Class Codes: A61Q 19/00 Preparations for care of the skin
• CPC Class Codes: C12Q 1/025 for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics antimicrobial activity C12Q1/18
• CPC Class Codes: G01N 2500/00 Screening for compounds of potential therapeutic value
• CPC Class Codes: G01N 33/56911 Bacteria

Abstract

A method for indentifying test agents that exhibit prebiotic activity on human skin commensal microorganisms and cosmetic compositions that include such agents. The method includes providing a test culture of a test agent, a human skin commensal microorganism and a minimal carbon medium. The method provides a time efficient and cost effective way to predict in vivo prebiotic activity of a test agent on skin commensal microorganisms.

Claims

1. A method of making a topical cosmetic composition, the method comprising:

(a) providing a first culture comprising a test agent, a quantity of a human skin commensal

microorganism, and a minimal carbon medium;

(b) determining a metabolite level or a replication level of the human skin commensal microorganism of the first culture;

(c) comparing the metabolite level or the replication level to a first control value, wherein the first control value is the metabolite level or replication level in a culture of the human skin commensal microorganism of the first culture that is grown without the test agent, and wherein the metabolite level correlates with the amount of growth;

(d) identifying the test agent as a prebiotic when the test agent increases the growth of the human skin commensal microorganism and when the metabolite level or replication level of the first culture is greater than the first control value; and

(e) combining a safe and effective amount of the prebiotic with a dermatologically acceptable carrier.

2. The method of claim 1, further comprising incorporating an ingredient selected from the group consisting of vitamins, peptides, peptide derivatives, sugar amines, sunscreen agents, ultraviolet light absorbers, colorants, surfactants, film-forming compositions, rheology modifiers and combinations thereof into the cosmetic composition.

3. The method of claim 1, wherein the minimal carbon medium has a carbon content of between about 0.001% and 0.1% by weight, based on the weight of the medium.

4. The method of claim 1, wherein the minimal carbon medium has a carbon content of less than 0.001% by weight, based on the weight of the media.

5. The method of claim 1, wherein the minimal carbon medium comprises NaCl, (NH₄)₂HPO₄, K₂HPO₄, and MgSO₄.7H₂O.

6. The method of claim 1, wherein the minimal carbon medium includes a supplement selected from the group consisting of iron, biotin, nicotinic acid, D-pantothenic acid, pyridoxal, pyridoxamine dihydrochloride, thiamine hydrochloride, glucose, galactose,

mannose, fructose, sucrose, lactose, maltose and combinations thereof.

7. The method of claim 1, wherein the minimal carbon medium is free of valine and arginine.

8. The method of claim 1, wherein the microorganism exhibits less than a 0.2 log increase in the number of CFUs after 24 hours in the minimal carbon medium.

9. The method of claim 1, wherein the metabolite level of the first culture is determined by measuring an amount of ATP present in the first culture with an ATP assay.

10. The method of claim 1, wherein the replication level is determined by a method selected from the group consisting of optical density measurement, DNA measurement by PCR, plate count, limiting dilution analysis, enzyme-linked immunosorbent assay, direct microscopic count, and labeling the microorganism with a light-emitting or colored compound and measuring the luminescence or color.

11. The method of claim 1, wherein the test agent comprises a botanical.

12. The method of claim 1, wherein the test agent comprises a microbial lysate.

13. The method of claim 1, wherein the human skin commensal microorganism is a species in one of the following genera:

Staphylococcus, Corynebacterium or Propionibacterium.

14. The method of claim 1, further comprising:

(a) providing a second culture that includes the test agent, a quantity of a second human skin commensal microorganism which is different from the first human skin commensal microorganism, and the minimal carbon medium;

(b) determining a second metabolite level or a replication level of the second culture;

(c) comparing the second metabolite level or the replication level of the second culture to a second control value, wherein the second control value is the second metabolite level or replication level in a culture of the human skin commensal microorganism of the second culture that is grown without the test agent, and wherein the second metabolite level correlates with the amount of growth; and

(d) identifying the test agent as a selective prebiotic when the test agent decreases the growth of the second human skin commensal microorganism and when the metabolite level or the replication level in the first culture is greater than the first control value and the metabolite level or the replication level in the second culture is less than the second control value.

15. The method of claim 14, further comprising:

(a) providing a third culture that includes the test agent, a quantity of a third human skin commensal microorganism that is different from the first and second human skin commensal microorganisms, and the minimal carbon medium; and

(b) identifying the test agent as a selective prebiotic when the test agent increases or decreases the growth of the third human skin commensal microorganism and when the metabolite level of a third metabolite or the replication level of the third culture is greater than or less than the third control value, wherein the third control value is the third metabolite level or replication level in a culture of the human skin commensal microorganism of the third culture that is grown without the test agent, and wherein the third metabolite level correlates with the amount of growth.

16. The method of claim 1, further comprising:

(a) providing a second culture that includes the test agent, a quantity of a second human skin commensal microorganism which is different from the first human skin commensal microorganism, and the minimal carbon medium;

(b) determining the metabolite level or a replication level of the second culture;

(c) comparing the metabolite level or the replication level of the second culture to a second control value, wherein the second control value is the metabolite level or replication level in a culture of the human skin commensal microorganism of the second culture that is grown without the test agent; and

(d) identifying the test agent as a broad spectrum prebiotic if the test agent increases the growth of the second human skin commensal microorganism and if the metabolite level or the replication level of the first and second cultures is greater than the first and second control values, respectively.

17. The method of claim 16, further comprising:

(a) a third culture that includes the test agent, a quantity of a third human skin commensal microorganism that is different from the first and second human skin commensal microorganisms, and the minimal carbon medium; and

(b) identifying the test agent as a broad spectrum prebiotic if the metabolite level or the replication level of the third culture is greater than the third control value, wherein the third control value is the metabolite level or replication level in a culture of the human skin commensal microorganism of the third culture that is grown without the test agent.

18. A method of making a topical cosmetic composition, the method comprising:

(a) providing a culture that includes a test agent and a quantity of a human skin commensal

microorganism;

(b) determining a metabolite level of the culture;

(c) comparing the metabolite level of the culture to a first control value, wherein the first control value is the metabolite level in a culture of the human skin commensal microorganism culture that is grown without the test agent, and wherein the metabolite level correlates with the amount of growth;

(d) performing a plate count assay using the culture when the metabolite level of the culture is greater than the first control value, wherein the greater metabolite level results from the test agent increasing the growth of the human skin commensal microorganism;

(e) comparing the number of colonies present in the plate count assay to a second control value, wherein the second control value is the number of colonies in a plate count assay of a culture of the human skin commensal microorganism that is grown without the test agent;

(f) identifying the test agent as a prebiotic agent if the number of colonies present in the plate

count assay of step (d) is greater than the second control value; and

(g) combining a safe and effective amount of the prebiotic agent with a dermatologically acceptable carrier.